Bruce Booth, Director, on June 17, 2026, sold 478,198 shares in Kymera Therapeutics (KYMR) for $45,293,294. Following the Form 4 filing with the SEC, Booth has control over a total of 4,108,316 common shares of the company, with 4,108,316 controlled indirectly.
SEC Filing: